公司问答丨赛伦生物：除了针对蜂毒、蛇毒毒素中毒布局的抗血清新药研发项目 公司尚未在其他动物毒素中毒上布局新药项目

Core Viewpoint - The company has received acceptance for its new drug application for antivenom serum targeting bee venom, but currently has no plans to expand its antitoxin technology platform to other animal toxins such as scorpion or spider venom [1] Group 1 - The company confirmed its focus on developing new drug projects specifically for antivenom against bee and snake venom toxins [1] - There are no ongoing new drug projects related to other animal toxins at this time [1] - The company will disclose any officially launched new drug research projects in its regular reports [1]